×

uniQure to Present at Upcoming Investor Conferences in New York City

AMSTERDAM, the Netherlands, May 12, 2016 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that its management will be presenting at the below listed investor conferences in May and June, 2016.

  • Piper Jaffray GenomeRx Symposium

Venue: The InterContinental New York Barclay Hotel, New York City
Title: Getting to the Heart (& Muscle) of the Gene Therapy Matter
Presenter: Christian Meyer, Chief Medical Officer
Date and Time: May 17, 2016: 10.40 AM EDT

  • 2016 UBS Global Healthcare Conference

Venue: Grand Hyatt New York Hotel, New York City
Presenter: Daniel Soland, Chief Executive Officer
Date and Time: May 24, 2016: 08.00 AM EDT
Webcast: A webcast of the presentation will be available through the details listed below

  • Jefferies 2016 Healthcare Conference

Venue: Grand Hyatt New York Hotel, New York City
Presenter: Matt Kapusta, Chief Financial Officer
Date and Time: June 10, 2016: 11.00 AM EDT

The webcast, including a slide presentation at the 2016 UBS Global Healthcare Conference, can be accessed through the following link: https://cc.talkpoint.com/ubsx001/052316a_ae/?entity=47_SI2EH82 or by accessing the link displayed in the "Events" section on the "Media" page of the uniQure website at: http://www.uniqure.com/news/calendar-of-events/. The replay of the webcast will be available one hour after the conclusion of the live event and archived on the uniQure website for at least 30 days following the webcast.

About uniQure

uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases. www.uniQure.com

CONTACT: uniQure: Eva Mulder Direct : +31 20 240 6103 Main: +31 20 240 6000 e.mulder@uniQure.com Media inquiries: Gretchen Schweitzer or Stephanie May MacDougall Biomedical Communications Direct: +49 172 861 8540 or +49 175 5711562 Main: +49 89 2424 3494 or +1 781 235 3060 gschweitzer@macbiocom.comSource: uniQure